Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISUALIZE: OPN-375 in Nasal Polyps
NCT03591068Phase 3Completed
- Sponsor
- OptiNose
- Start
- Jun 2018
- Primary completion
- Feb 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fluticasone propionate in nasal polyps, sponsored by OptiNose. Started Jun 2018; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT03591068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03591068.